High HDL may reduce risk of prostate cancer recurrence
the ONA take:
According to a new study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers at Duke University School of Medicine in Durham, North Carolina, have found that high cholesterol may be associated with an increased risk for developing prostate cancer.
For the study, the researchers analyzed blood lipid levels from 843 men diagnosed with prostate cancer who had undergone a radical prostatectomy. All men had no history of taking statin medications that lower cholesterol.
Of all samples, 325 men had abnormal cholesterol levels and 263 had abnormal triglyceride levels. In addition, 293 men had elevated prostate-specific antigen (PSA) levels, which indicate that those men experienced a prostate cancer recurrence. Men with triglyceride levels above 150 mg/dL were 35% more likely to experience a prostate cancer recurrence compared with men with normal triglyceride levels under 150 mg/dL.
Furthermore, men with total cholesterol levels over 200 mg/dL had a 9% increased risk for experiencing a prostate cancer recurrence for every 10 mg/dL increase over 200 mg/dL. By contrast, men with high levels of high density lipoprotein (HDL) have a 39% decreased risk of prostate cancer recurrence for every 10 mg/dL increase over 40 mg/dL.
The findings suggest that the risk for prostate cancer recurrence may be lowered by controlling dyslipidemia.
High cholesterol may be associated with an increased risk for developing prostate cancer.
Among men who have surgery for prostate cancer, those who have high total cholesterol and triglyceride levels - two types of fat found in blood - may be at increased risk of disease recurrence. This is according to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
After skin cancer, prostate cancer is the most common cancer in American men. This year, 233,000 men will be diagnosed with prostate cancer, and 29,480 will die from it. According to the research team, including Emma Allot, PhD, postdoctoral associate at Duke University School of Medicine in Durham, NC, laboratory studies have linked high cholesterol levels to prostate cancer, but population-based studies looking at this association have been unclear.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|